Sanjibani Medisales Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.69 Cr
as on 18-07-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.10 Cr
as on 18-07-2024
- Revenue 10.84%
(FY 2022)
- Profit 8.11%
(FY 2022)
- Ebitda 45.55%
(FY 2022)
- Net Worth 39.51%
(FY 2022)
- Total Assets 12.13%
(FY 2022)
About Sanjibani Medisales
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.69 Cr.
The company currently has active open charges totaling ₹40.10 Cr.
Mita Das, Rajarshi Das, Anjan Das, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100WB2009PTC138275
- Company No.
138275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanjibani Medisales?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mita Das  | Director | 07-Sep-2009 | Current |
| Rajarshi Das | Director | 07-Sep-2009 | Current |
| Anjan Das | Director | 01-Mar-2021 | Current |
| Alok Maity | Director | 02-Aug-2019 | Current |
Financial Performance of Sanjibani Medisales.
Sanjibani Medisales Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.84% increase. The company also saw a slight improvement in profitability, with a 8.11% increase in profit. The company's net worth Soared by an impressive increase of 39.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjibani Medisales?
In 2022, Sanjibani Medisales had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bmrc Jharsuguda Cardiac Care Hospital Private LimitedActive 11 months 20 days
Mita Das, Rajarshi Das and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 Sep 2023 | ₹25.00 Cr | Open |
Axis Bank Limited Creation Date: 30 May 2023 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Aug 2021 | ₹1.75 M | Open |
How Many Employees Work at Sanjibani Medisales?
Sanjibani Medisales has a workforce of 39 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjibani Medisales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjibani Medisales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
